Mexaratio

Paracetamol, the active ingredient in Mexaratio, is an analgesic presented as an oral tablet for oral use. It reduces pain and fever and is commonly used in adults and children for mild to moderate discomfort.

GNH USA supplies Mexaratio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Mexaratio is manufactured under EU GMP guidelines and undergoes comprehensive testing to ensure purity and potency.

Paracetamol acts as an analgesic and antipyretic, relieving pain and reducing fever.

Pain: alleviates mild to moderate pain such as headache, toothache, or muscle aches. Fever: reduces elevated body temperature in febrile illnesses. Cold symptoms: eases discomfort associated with common cold and flu.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset may occur. - Skin rash: transient erythema or itching. - Headache: occasional mild headache. - Elevated liver enzymes: mild, reversible increase in liver function tests.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, especially with overdose. - Stevens‑Johnson syndrome: rare severe skin reaction. - Blood disorders: agranulocytosis or thrombocytopenia. - Anaphylaxis: rare allergic reaction with breathing difficulty.

When using Mexaratio, consider the following precautions.

Dosage adjustment: reduce dose in patients with hepatic impairment. Alcohol use: avoid excessive alcohol while taking. Age restrictions: use with caution in children under 2 years. Drug interactions: review concomitant medications for potential interactions. Pregnancy and lactation: safety not established; consult healthcare professional. Store at below 25°C: keep in original packaging, protect from moisture.

Paracetamol may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, monitor INR. - Rifampicin: may reduce paracetamol plasma levels. - High-dose alcohol: heightened risk of liver toxicity.

Moderate Interactions (Monitor Closely): - Carbamazepine: may increase metabolism, reduce effect. - Phenobarbital: may lower plasma concentration. - Isoniazid: may increase risk of hepatotoxicity.